Cancer Institute– A national cancer institute
designated cancer center

Edgar Engleman

Back to Profile

Publication Details

  • Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial.

    van Vollenhoven RF, Engleman EG, McGuire JL. Arthritis Rheum. 1995; 38 (12): 1826-31

    To determine if dehydroepiandrosterone (DHEA) is beneficial in the treatment of systemic lupus erythematosus (SLE).

    PubMedID: 8849355

Stanford Medicine Resources:

Footer Links: